EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Takahiro Katsumata
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ibaraki, T.
Right arrow Articles by Miyazaki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibaraki, T.
Right arrow Articles by Miyazaki, M.
Related Collections
Right arrow Lung - basic science
Right arrow Lung - cancer

Eur J Cardiothorac Surg 2005;28:617-621
© 2005 Elsevier Science NL


Original articles

The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer

Toshihiko Ibaraki a , b , Michiko Muramatsu a , Shinji Takai a , * , Denan Jin a , Hiroshi Maruyama c , Tatsuhiko Orino d , Takahiro Katsumata b , Mizuo Miyazaki a

a Department of Pharmacology, Osaka Medical College, Takatsuki City, Osaka 569-8686, Japan
b Department of Thoracic and Cardiovascular Surgery, Osaka Medical College, Takatsuki City, Osaka 569-8686, Japan
c Department of Pathology, Hoshigaoka Koseinenkin Hospital, 4-8-1, Hoshigaoka, Hirakata City, Osaka 573-8511, Japan
d Department of Thoracic Surgery, Hoshigaoka Koseinenkin Hospital, 4-8-1, Hoshigaoka, Hirakata City, Osaka 573-8511, Japan

Received 25 March 2005; received in revised form 6 June 2005; accepted 9 June 2005.

* Corresponding author. Tel.: +81 726 84 7292; fax: +81 726 84 6518. (Email: pha010{at}art.osaka-med.ac.jp).

Abstract

Objective: There are two types of human mast cells, tryptase-positive mast cells (MCT) and tryptase- and chymase-positive mast cells (MCTC). Although MCT have been reported to be related to the generation of angiogenesis, little is known about the involvement of MCTC in tumor angiogenesis. In this study, to clarify the relationship between MCTC and lung cancer angiogenesis, we evaluated MCTC, MCT, and microvessel counts in normal, border, and central lung cancer regions. Methods: Tumor sections from 32 cases of adenocarcinoma and 13 cases of squamous cell carcinoma were immunostained for chymase to evaluate MCTC, tryptase to evaluate MCT, and CD34 to evaluate microvessel counts. Results: Both MCTC and MCT counts in the border lung cancer region were significantly higher than in the central region, and the MCTC and MCT counts in the central region were significantly higher than those in the normal regions. The microvessel counts in the border region were higher than those in the central region. The ratio of MCTC to MCT in the border region, but not in the central region, was significantly higher than that in the normal region. In the border region, significant correlations not only between MCT and microvessel count, but also between MCTC and microvessel count were observed. In the central region, a significant correlation between MCTC and the microvessel count was observed, but there was no significant correlation between MCT and the microvessel count. Conclusions: These findings suggest that MCTC may be involved in the pathogenesis of angiogenesis in lung cancer.

Key Words: Angiogenesis • Lung cancer • Chymase • Mast cells • Human




This article has been cited by other articles:


Home page
haematolHome page
L. Mileshkin, D. Honemann, P. Gambell, M. Trivett, Y. Hayakawa, M. Smyth, V. Beshay, D. Ritchie, P. Simmons, A. D. Milner, et al.
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome
Haematologica, August 1, 2007; 92(8): 1075 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Akgul and G. P Noon
Comparison of mast cell properties and myocardial structure in dilated and ischemic hearts under mechanical circulatory support.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 637 - 637.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Takai, T. Ibaraki, M. Muramatsu, and M. Miyazaki
Reply to ozdemir.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 639 - 639.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
O. Ozdemir
The role of mast cell and mast cell subtypes (MC(T) and MC(CT)) in tumor angiogenesis.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 638 - 639.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.